Showing results (1-10 of 139) with videos related to
Sort By:
Pageof 14
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1993
Emerging antimicrobial resistance and the immunocompromised hostD M Shlaes, B Binczewski, L B RiceEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1990
Enterococcal resistance to vancomycin and related cyclic glycopeptide antibioticsD M Shlaes, B BinczewskiTrends in Microbiology|October 1, 1994
Bacterial resistance to the cyclic glycopeptidesD M Shlaes, L B RicePediatric Clinics of North America|June 1, 1995
Vancomycin resistance in the enterococcus. Relevance in pediatricsL B Rice, D M ShlaesAntimicrobial Agents and Chemotherapy|November 1, 1994
In vivo efficacies of beta-lactam-beta-lactamase inhibitor combinations against a TEM-26-producing strain of Klebsiella pneumoniaeL B Rice, L L Carias, D M ShlaesAntimicrobial Agents and Chemotherapy|March 1, 1993
Efficacy of ampicillin-sulbactam versus that of cefoxitin for treatment of Escherichia coli infections in a rat intra-abdominal abscess modelL B Rice, L L Carias, D M ShlaesAntimicrobial Agents and Chemotherapy|May 1, 1993
Resistance to cefoperazone-sulbactam in Klebsiella pneumoniae: evidence for enhanced resistance resulting from the coexistence of two different resistance mechanismsL B Rice, L L Carias, L Etter, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 1996
Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical CenterL B Rice, E C Eckstein, J DeVente, et al.Antimicrobial Agents and Chemotherapy|June 1, 1993
Constitutively vancomycin-resistant Enterococcus faecium resistant to synergistic beta-lactam combinationsM Green, B Binczewski, A W Pasculle, et al.The Journal of Infectious Diseases|January 1, 1996
Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapyL B Rice, L L Carias, R A Bonomo, et al.Pageof 14